The Evolving Treatment Paradigm for Stage I-IIIA NSCLC - Episode 1
A panel of lung cancer experts provides an overview of molecular testing in early-stage non-small cell lung cancer (NSCLC) and recommendations for biomarkers to test for and at what treatment stages to perform testing.